The minimal IFN‐β expression observed upon treating Pan02 cells with both C‐REV and 2′3′‐cGAMP further corroborates the inability of STING agonists to affect C‐REV replication in tumor cells (Fig. 1E). Here, STING1 is linked to neoplasm.